img

Global Animal Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Animal Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Animal vaccines control the transmission diseases, thus providing protection to animal and human health.
The global Animal Vaccines market size was US$ 7698.3 million in 2022 and is forecast to a readjusted size of US$ 11000 million by 2034 with a CAGR of 4.8% during the forecast period 2024-2034.
The animal vaccines market is segmented on the basis of product type, animal type, and geography. By product type, the industry is categorized into attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines.
In terms of sales (consumption) side, this report focuses on the sales of Animal Vaccines by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Animal Vaccines market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Animal Vaccines market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Zoetis
Merck Animal Health
Boehringer Ingelheim
Elanco
Virbac
Vetoquinol
Phibro Animal Health
Hester Biosciences
Hipra
IDT Biologika
Biogenesis Bago
Tianjin Ringpu
China Animal Husbandry
By Type
Attenuated Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
Conjugate Vaccines
Recombinant Vaccines
DNA Vaccines
By Application
Companion Animals
Cattle
Pigs
Poultry
Sheep
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Animal Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Animal Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Animal Vaccines Definition
1.2 Market by Type
1.2.1 Global Animal Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Subunit Vaccines
1.2.5 Toxoid Vaccines
1.2.6 Conjugate Vaccines
1.2.7 Recombinant Vaccines
1.2.8 DNA Vaccines
1.3 Market Segment by Application
1.3.1 Global Animal Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Companion Animals
1.3.3 Cattle
1.3.4 Pigs
1.3.5 Poultry
1.3.6 Sheep
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Animal Vaccines Sales
2.1 Global Animal Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global Animal Vaccines Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Animal Vaccines Revenue by Region
2.3.1 Global Animal Vaccines Revenue by Region (2018-2024)
2.3.2 Global Animal Vaccines Revenue by Region (2024-2034)
2.4 Global Animal Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Animal Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Animal Vaccines Sales Quantity by Region
2.6.1 Global Animal Vaccines Sales Quantity by Region (2018-2024)
2.6.2 Global Animal Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Animal Vaccines Sales Quantity by Manufacturers
3.1.1 Global Animal Vaccines Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Animal Vaccines Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Animal Vaccines Sales in 2022
3.2 Global Animal Vaccines Revenue by Manufacturers
3.2.1 Global Animal Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Animal Vaccines Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Animal Vaccines Revenue in 2022
3.3 Global Animal Vaccines Sales Price by Manufacturers
3.4 Global Key Players of Animal Vaccines, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Animal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Animal Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Animal Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Animal Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Animal Vaccines Sales Quantity by Type
4.1.1 Global Animal Vaccines Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Animal Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Animal Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global Animal Vaccines Revenue by Type
4.2.1 Global Animal Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Animal Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global Animal Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Animal Vaccines Price by Type
4.3.1 Global Animal Vaccines Price by Type (2018-2024)
4.3.2 Global Animal Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Animal Vaccines Sales Quantity by Application
5.1.1 Global Animal Vaccines Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Animal Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Animal Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global Animal Vaccines Revenue by Application
5.2.1 Global Animal Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Animal Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global Animal Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Animal Vaccines Price by Application
5.3.1 Global Animal Vaccines Price by Application (2018-2024)
5.3.2 Global Animal Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America Animal Vaccines Sales by Company
6.1.1 North America Animal Vaccines Revenue by Company (2018-2024)
6.1.2 North America Animal Vaccines Sales Quantity by Company (2018-2024)
6.2 North America Animal Vaccines Market Size by Type
6.2.1 North America Animal Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America Animal Vaccines Revenue by Type (2018-2034)
6.3 North America Animal Vaccines Market Size by Application
6.3.1 North America Animal Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America Animal Vaccines Revenue by Application (2018-2034)
6.4 North America Animal Vaccines Market Size by Country
6.4.1 North America Animal Vaccines Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Animal Vaccines Revenue by Country (2018-2034)
6.4.3 North America Animal Vaccines Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Animal Vaccines Sales by Company
7.1.1 Europe Animal Vaccines Sales Quantity by Company (2018-2024)
7.1.2 Europe Animal Vaccines Revenue by Company (2018-2024)
7.2 Europe Animal Vaccines Market Size by Type
7.2.1 Europe Animal Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe Animal Vaccines Revenue by Type (2018-2034)
7.3 Europe Animal Vaccines Market Size by Application
7.3.1 Europe Animal Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe Animal Vaccines Revenue by Application (2018-2034)
7.4 Europe Animal Vaccines Market Size by Country
7.4.1 Europe Animal Vaccines Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Animal Vaccines Revenue by Country (2018-2034)
7.4.3 Europe Animal Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Animal Vaccines Sales by Company
8.1.1 China Animal Vaccines Sales Quantity by Company (2018-2024)
8.1.2 China Animal Vaccines Revenue by Company (2018-2024)
8.2 China Animal Vaccines Market Size by Type
8.2.1 China Animal Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China Animal Vaccines Revenue by Type (2018-2034)
8.3 China Animal Vaccines Market Size by Application
8.3.1 China Animal Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China Animal Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Animal Vaccines Sales by Company
9.1.1 APAC Animal Vaccines Sales Quantity by Company (2018-2024)
9.1.2 APAC Animal Vaccines Revenue by Company (2018-2024)
9.2 APAC Animal Vaccines Market Size by Type
9.2.1 APAC Animal Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC Animal Vaccines Revenue by Type (2018-2034)
9.3 APAC Animal Vaccines Market Size by Application
9.3.1 APAC Animal Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC Animal Vaccines Revenue by Application (2018-2034)
9.4 APAC Animal Vaccines Market Size by Region
9.4.1 APAC Animal Vaccines Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Animal Vaccines Revenue by Region (2018-2034)
9.4.3 APAC Animal Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Animal Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America Animal Vaccines Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Animal Vaccines Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Animal Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America Animal Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Animal Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Animal Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America Animal Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Animal Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Animal Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America Animal Vaccines Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Animal Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Animal Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Zoetis
11.1.1 Zoetis Company Information
11.1.2 Zoetis Overview
11.1.3 Zoetis Animal Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Zoetis Animal Vaccines Products and Services
11.1.5 Zoetis Animal Vaccines SWOT Analysis
11.1.6 Zoetis Recent Developments
11.2 Merck Animal Health
11.2.1 Merck Animal Health Company Information
11.2.2 Merck Animal Health Overview
11.2.3 Merck Animal Health Animal Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Merck Animal Health Animal Vaccines Products and Services
11.2.5 Merck Animal Health Animal Vaccines SWOT Analysis
11.2.6 Merck Animal Health Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Animal Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Boehringer Ingelheim Animal Vaccines Products and Services
11.3.5 Boehringer Ingelheim Animal Vaccines SWOT Analysis
11.3.6 Boehringer Ingelheim Recent Developments
11.4 Elanco
11.4.1 Elanco Company Information
11.4.2 Elanco Overview
11.4.3 Elanco Animal Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Elanco Animal Vaccines Products and Services
11.4.5 Elanco Animal Vaccines SWOT Analysis
11.4.6 Elanco Recent Developments
11.5 Virbac
11.5.1 Virbac Company Information
11.5.2 Virbac Overview
11.5.3 Virbac Animal Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Virbac Animal Vaccines Products and Services
11.5.5 Virbac Animal Vaccines SWOT Analysis
11.5.6 Virbac Recent Developments
11.6 Vetoquinol
11.6.1 Vetoquinol Company Information
11.6.2 Vetoquinol Overview
11.6.3 Vetoquinol Animal Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Vetoquinol Animal Vaccines Products and Services
11.6.5 Vetoquinol Animal Vaccines SWOT Analysis
11.6.6 Vetoquinol Recent Developments
11.7 Phibro Animal Health
11.7.1 Phibro Animal Health Company Information
11.7.2 Phibro Animal Health Overview
11.7.3 Phibro Animal Health Animal Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Phibro Animal Health Animal Vaccines Products and Services
11.7.5 Phibro Animal Health Animal Vaccines SWOT Analysis
11.7.6 Phibro Animal Health Recent Developments
11.8 Hester Biosciences
11.8.1 Hester Biosciences Company Information
11.8.2 Hester Biosciences Overview
11.8.3 Hester Biosciences Animal Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Hester Biosciences Animal Vaccines Products and Services
11.8.5 Hester Biosciences Animal Vaccines SWOT Analysis
11.8.6 Hester Biosciences Recent Developments
11.9 Hipra
11.9.1 Hipra Company Information
11.9.2 Hipra Overview
11.9.3 Hipra Animal Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Hipra Animal Vaccines Products and Services
11.9.5 Hipra Animal Vaccines SWOT Analysis
11.9.6 Hipra Recent Developments
11.10 IDT Biologika
11.10.1 IDT Biologika Company Information
11.10.2 IDT Biologika Overview
11.10.3 IDT Biologika Animal Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 IDT Biologika Animal Vaccines Products and Services
11.10.5 IDT Biologika Animal Vaccines SWOT Analysis
11.10.6 IDT Biologika Recent Developments
11.11 Biogenesis Bago
11.11.1 Biogenesis Bago Company Information
11.11.2 Biogenesis Bago Overview
11.11.3 Biogenesis Bago Animal Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Biogenesis Bago Animal Vaccines Products and Services
11.11.5 Biogenesis Bago Recent Developments
11.12 Tianjin Ringpu
11.12.1 Tianjin Ringpu Company Information
11.12.2 Tianjin Ringpu Overview
11.12.3 Tianjin Ringpu Animal Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 Tianjin Ringpu Animal Vaccines Products and Services
11.12.5 Tianjin Ringpu Recent Developments
11.13 China Animal Husbandry
11.13.1 China Animal Husbandry Company Information
11.13.2 China Animal Husbandry Overview
11.13.3 China Animal Husbandry Animal Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 China Animal Husbandry Animal Vaccines Products and Services
11.13.5 China Animal Husbandry Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Animal Vaccines Value Chain Analysis
12.2 Animal Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Animal Vaccines Production Mode & Process
12.4 Animal Vaccines Sales and Marketing
12.4.1 Animal Vaccines Sales Channels
12.4.2 Animal Vaccines Distributors
12.5 Animal Vaccines Customers
13 Market Dynamics
13.1 Animal Vaccines Industry Trends
13.2 Animal Vaccines Market Drivers
13.3 Animal Vaccines Market Challenges
13.4 Animal Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Animal Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Attenuated Vaccines
Table 3. Major Manufacturers of Inactivated Vaccines
Table 4. Major Manufacturers of Subunit Vaccines
Table 5. Major Manufacturers of Toxoid Vaccines
Table 6. Major Manufacturers of Conjugate Vaccines
Table 7. Major Manufacturers of Recombinant Vaccines
Table 8. Major Manufacturers of DNA Vaccines
Table 9. Global Animal Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 10. Global Animal Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 11. Global Animal Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 12. Global Animal Vaccines Revenue Market Share by Region (2018-2024)
Table 13. Global Animal Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 14. Global Animal Vaccines Revenue Market Share by Region (2024-2034)
Table 15. Global Animal Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 16. Global Animal Vaccines Sales by Region (2018-2024) & (K Units)
Table 17. Global Animal Vaccines Sales Market Share by Region (2018-2024)
Table 18. Global Animal Vaccines Sales by Region (2024-2034) & (K Units)
Table 19. Global Animal Vaccines Sales Market Share by Region (2024-2034)
Table 20. Global Animal Vaccines Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 21. Global Animal Vaccines Sales Quantity Share by Manufacturers (2018-2024)
Table 22. Global Animal Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 23. Global Animal Vaccines Revenue Share by Manufacturers (2018-2024)
Table 24. Global Animal Vaccines Price by Manufacturers 2018-2024 (USD/Unit)
Table 25. Global Key Players of Animal Vaccines, Industry Ranking, 2021 VS 2022
Table 26. Global Animal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Animal Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal Vaccines as of 2022)
Table 28. Global Key Manufacturers of Animal Vaccines, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of Animal Vaccines, Product Offered and Application
Table 30. Global Key Manufacturers of Animal Vaccines, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Animal Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 33. Global Animal Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 34. Global Animal Vaccines Sales Quantity Share by Type (2018-2024)
Table 35. Global Animal Vaccines Sales Quantity Share by Type (2024-2034)
Table 36. Global Animal Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 37. Global Animal Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 38. Global Animal Vaccines Revenue Share by Type (2018-2024)
Table 39. Global Animal Vaccines Revenue Share by Type (2024-2034)
Table 40. Animal Vaccines Price by Type (2018-2024) & (USD/Unit)
Table 41. Global Animal Vaccines Price Forecast by Type (2024-2034) & (USD/Unit)
Table 42. Global Animal Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 43. Global Animal Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 44. Global Animal Vaccines Sales Quantity Share by Application (2018-2024)
Table 45. Global Animal Vaccines Sales Quantity Share by Application (2024-2034)
Table 46. Global Animal Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 47. Global Animal Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 48. Global Animal Vaccines Revenue Share by Application (2018-2024)
Table 49. Global Animal Vaccines Revenue Share by Application (2024-2034)
Table 50. Animal Vaccines Price by Application (2018-2024) & (USD/Unit)
Table 51. Global Animal Vaccines Price Forecast by Application (2024-2034) & (USD/Unit)
Table 52. North America Animal Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 53. North America Animal Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 54. North America Animal Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 55. North America Animal Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 56. North America Animal Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 57. North America Animal Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 58. North America Animal Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 59. North America Animal Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 60. North America Animal Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 61. North America Animal Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 62. North America Animal Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 63. North America Animal Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 64. North America Animal Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 65. North America Animal Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 66. North America Animal Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 67. Europe Animal Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 68. Europe Animal Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 69. Europe Animal Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 70. Europe Animal Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 71. Europe Animal Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 72. Europe Animal Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 73. Europe Animal Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 74. Europe Animal Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 75. Europe Animal Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 76. Europe Animal Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 77. Europe Animal Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 78. Europe Animal Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 79. Europe Animal Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 80. Europe Animal Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 81. Europe Animal Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 82. China Animal Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 83. China Animal Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 84. China Animal Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 85. China Animal Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 86. China Animal Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 87. China Animal Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 88. China Animal Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 89. China Animal Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 90. China Animal Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 91. China Animal Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 92. APAC Animal Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 93. APAC Animal Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 94. APAC Animal Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 95. APAC Animal Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 96. APAC Animal Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 97. APAC Animal Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 98. APAC Animal Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 99. APAC Animal Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 100. APAC Animal Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 101. APAC Animal Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 102. APAC Animal Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 103. APAC Animal Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 104. APAC Animal Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 105. APAC Animal Vaccines Sales Quantity by Region (2018-2024) & (K Units)
Table 106. APAC Animal Vaccines Sales Quantity by Region (2024-2034) & (K Units)
Table 107. Middle East, Africa and Latin America Animal Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Animal Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Animal Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 110. Middle East, Africa and Latin America Animal Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 111. Middle East, Africa and Latin America Animal Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 112. Middle East, Africa and Latin America Animal Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Animal Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 114. Middle East, Africa and Latin America Animal Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 115. Middle East, Africa and Latin America Animal Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Animal Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Animal Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 118. Middle East, Africa and Latin America Animal Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 119. Middle East, Africa and Latin America Animal Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 120. Middle East, Africa and Latin America Animal Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 121. Middle East, Africa and Latin America Animal Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 122. Zoetis Company Information
Table 123. Zoetis Description and Overview
Table 124. Zoetis Animal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 125. Zoetis Animal Vaccines Product and Services
Table 126. Zoetis Animal Vaccines SWOT Analysis
Table 127. Zoetis Recent Developments
Table 128. Merck Animal Health Company Information
Table 129. Merck Animal Health Description and Overview
Table 130. Merck Animal Health Animal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 131. Merck Animal Health Animal Vaccines Product and Services
Table 132. Merck Animal Health Animal Vaccines SWOT Analysis
Table 133. Merck Animal Health Recent Developments
Table 134. Boehringer Ingelheim Company Information
Table 135. Boehringer Ingelheim Description and Overview
Table 136. Boehringer Ingelheim Animal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 137. Boehringer Ingelheim Animal Vaccines Product and Services
Table 138. Boehringer Ingelheim Animal Vaccines SWOT Analysis
Table 139. Boehringer Ingelheim Recent Developments
Table 140. Elanco Company Information
Table 141. Elanco Description and Overview
Table 142. Elanco Animal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 143. Elanco Animal Vaccines Product and Services
Table 144. Elanco Animal Vaccines SWOT Analysis
Table 145. Elanco Recent Developments
Table 146. Virbac Company Information
Table 147. Virbac Description and Overview
Table 148. Virbac Animal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 149. Virbac Animal Vaccines Product and Services
Table 150. Virbac Animal Vaccines SWOT Analysis
Table 151. Virbac Recent Developments
Table 152. Vetoquinol Company Information
Table 153. Vetoquinol Description and Overview
Table 154. Vetoquinol Animal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 155. Vetoquinol Animal Vaccines Product and Services
Table 156. Vetoquinol Animal Vaccines SWOT Analysis
Table 157. Vetoquinol Recent Developments
Table 158. Phibro Animal Health Company Information
Table 159. Phibro Animal Health Description and Overview
Table 160. Phibro Animal Health Animal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 161. Phibro Animal Health Animal Vaccines Product and Services
Table 162. Phibro Animal Health Animal Vaccines SWOT Analysis
Table 163. Phibro Animal Health Recent Developments
Table 164. Hester Biosciences Company Information
Table 165. Hester Biosciences Description and Overview
Table 166. Hester Biosciences Animal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 167. Hester Biosciences Animal Vaccines Product and Services
Table 168. Hester Biosciences Animal Vaccines SWOT Analysis
Table 169. Hester Biosciences Recent Developments
Table 170. Hipra Company Information
Table 171. Hipra Description and Overview
Table 172. Hipra Animal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 173. Hipra Animal Vaccines Product and Services
Table 174. Hipra Animal Vaccines SWOT Analysis
Table 175. Hipra Recent Developments
Table 176. IDT Biologika Company Information
Table 177. IDT Biologika Description and Overview
Table 178. IDT Biologika Animal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 179. IDT Biologika Animal Vaccines Product and Services
Table 180. IDT Biologika Animal Vaccines SWOT Analysis
Table 181. IDT Biologika Recent Developments
Table 182. Biogenesis Bago Company Information
Table 183. Biogenesis Bago Description and Overview
Table 184. Biogenesis Bago Animal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 185. Biogenesis Bago Animal Vaccines Product and Services
Table 186. Biogenesis Bago Recent Developments
Table 187. Tianjin Ringpu Company Information
Table 188. Tianjin Ringpu Description and Overview
Table 189. Tianjin Ringpu Animal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 190. Tianjin Ringpu Animal Vaccines Product and Services
Table 191. Tianjin Ringpu Recent Developments
Table 192. China Animal Husbandry Company Information
Table 193. China Animal Husbandry Description and Overview
Table 194. China Animal Husbandry Animal Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 195. China Animal Husbandry Animal Vaccines Product and Services
Table 196. China Animal Husbandry Recent Developments
Table 197. Key Raw Materials Lists
Table 198. Raw Materials Key Suppliers Lists
Table 199. Animal Vaccines Distributors List
Table 200. Animal Vaccines Customers List
Table 201. Animal Vaccines Market Trends
Table 202. Animal Vaccines Market Drivers
Table 203. Animal Vaccines Market Challenges
Table 204. Animal Vaccines Market Restraints
Table 205. Research Programs/Design for This Report
Table 206. Key Data Information from Secondary Sources
Table 207. Key Data Information from Primary Sources
List of Figures
Figure 1. Animal Vaccines Product Picture
Figure 2. Global Animal Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Animal Vaccines Market Share by Type in 2022 & 2034
Figure 4. Attenuated Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Subunit Vaccines Product Picture
Figure 7. Toxoid Vaccines Product Picture
Figure 8. Conjugate Vaccines Product Picture
Figure 9. Recombinant Vaccines Product Picture
Figure 10. DNA Vaccines Product Picture
Figure 11. Global Animal Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 12. Global Animal Vaccines Market Share by Application in 2022 & 2034
Figure 13. Companion Animals
Figure 14. Cattle
Figure 15. Pigs
Figure 16. Poultry
Figure 17. Sheep
Figure 18. Animal Vaccines Report Years Considered
Figure 19. Global Animal Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 20. Global Animal Vaccines Revenue 2018-2034 (US$ Million)
Figure 21. Global Animal Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 22. Global Animal Vaccines Sales Quantity 2018-2034 (K Units)
Figure 23. Global Animal Vaccines Sales Quantity Market Share by Region (2018-2024)
Figure 24. Global Animal Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 25. North America Animal Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. North America Animal Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Europe Animal Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. Europe Animal Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 29. China Animal Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 30. China Animal Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 31. APAC Animal Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 32. APAC Animal Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 33. Middle East, Africa and Latin America Animal Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 34. Middle East, Africa and Latin America Animal Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 35. The Top 10 and Top 5 Players Market Share by Animal Vaccines Sales Quantity in 2022
Figure 36. The Top 10 and Top 5 Players Market Share by Animal Vaccines Revenue in 2022
Figure 37. Animal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 38. Global Animal Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 39. Global Animal Vaccines Revenue Market Share by Type (2018-2034)
Figure 40. Global Animal Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 41. Global Animal Vaccines Revenue Market Share by Application (2018-2034)
Figure 42. North America Animal Vaccines Revenue Market Share by Company in 2022
Figure 43. North America Animal Vaccines Sales Quantity Market Share by Company in 2022
Figure 44. North America Animal Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 45. North America Animal Vaccines Revenue Market Share by Type (2018-2034)
Figure 46. North America Animal Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 47. North America Animal Vaccines Revenue Market Share by Application (2018-2034)
Figure 48. North America Animal Vaccines Revenue Share by Country (2018-2034)
Figure 49. North America Animal Vaccines Sales Quantity Share by Country (2018-2034)
Figure 50. U.S. Animal Vaccines Revenue (2018-2034) & (US$ Million)
Figure 51. Canada Animal Vaccines Revenue (2018-2034) & (US$ Million)
Figure 52. Europe Animal Vaccines Sales Quantity Market Share by Company in 2022
Figure 53. Europe Animal Vaccines Revenue Market Share by Company in 2022
Figure 54. Europe Animal Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 55. Europe Animal Vaccines Revenue Market Share by Type (2018-2034)
Figure 56. Europe Animal Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 57. Europe Animal Vaccines Revenue Market Share by Application (2018-2034)
Figure 58. Europe Animal Vaccines Revenue Share by Country (2018-2034)
Figure 59. Europe Animal Vaccines Sales Quantity Share by Country (2018-2034)
Figure 60. Germany Animal Vaccines Revenue (2018-2034) & (US$ Million)
Figure 61. France Animal Vaccines Revenue (2018-2034) & (US$ Million)
Figure 62. U.K. Animal Vaccines Revenue (2018-2034) & (US$ Million)
Figure 63. Italy Animal Vaccines Revenue (2018-2034) & (US$ Million)
Figure 64. Russia Animal Vaccines Revenue (2018-2034) & (US$ Million)
Figure 65. China Animal Vaccines Sales Quantity Market Share by Company in 2022
Figure 66. China Animal Vaccines Revenue Market Share by Company in 2022
Figure 67. China Animal Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 68. China Animal Vaccines Revenue Market Share by Type (2018-2034)
Figure 69. China Animal Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 70. China Animal Vaccines Revenue Market Share by Application (2018-2034)
Figure 71. APAC Animal Vaccines Sales Quantity Market Share by Company in 2022
Figure 72. APAC Animal Vaccines Revenue Market Share by Company in 2022
Figure 73. APAC Animal Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 74. APAC Animal Vaccines Revenue Market Share by Type (2018-2034)
Figure 75. APAC Animal Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 76. APAC Animal Vaccines Revenue Market Share by Application (2018-2034)
Figure 77. APAC Animal Vaccines Revenue Share by Region (2018-2034)
Figure 78. APAC Animal Vaccines Sales Quantity Share by Region (2018-2034)
Figure 79. Japan Animal Vaccines Revenue (2018-2034) & (US$ Million)
Figure 80. South Korea Animal Vaccines Revenue (2018-2034) & (US$ Million)
Figure 81. China Taiwan Animal Vaccines Revenue (2018-2034) & (US$ Million)
Figure 82. Southeast Asia Animal Vaccines Revenue (2018-2034) & (US$ Million)
Figure 83. India Animal Vaccines Revenue (2018-2034) & (US$ Million)
Figure 84. Middle East, Africa and Latin America Animal Vaccines Sales Quantity Market Share by Company in 2022
Figure 85. Middle East, Africa and Latin America Animal Vaccines Revenue Market Share by Company in 2022
Figure 86. Middle East, Africa and Latin America Animal Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 87. Middle East, Africa and Latin America Animal Vaccines Revenue Market Share by Type (2018-2034)
Figure 88. Middle East, Africa and Latin America Animal Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 89. Middle East, Africa and Latin America Animal Vaccines Revenue Market Share by Application (2018-2034)
Figure 90. Middle East, Africa and Latin America Animal Vaccines Sales Quantity Share by Country (2018-2034)
Figure 91. Middle East, Africa and Latin America Animal Vaccines Revenue Share by Country (2018-2034)
Figure 92. Brazil Animal Vaccines Revenue (2018-2034) & (US$ Million)
Figure 93. Mexico Animal Vaccines Revenue (2018-2034) & (US$ Million)
Figure 94. Turkey Animal Vaccines Revenue (2018-2034) & (US$ Million)
Figure 95. Israel Animal Vaccines Revenue (2018-2034) & (US$ Million)
Figure 96. GCC Countries Animal Vaccines Revenue (2018-2034) & (US$ Million)
Figure 97. Animal Vaccines Value Chain
Figure 98. Animal Vaccines Production Process
Figure 99. Channels of Distribution (Direct Vs Distribution)
Figure 100. Distributors Profiles
Figure 101. Bottom-up and Top-down Approaches for This Report
Figure 102. Data Triangulation
Figure 103. Key Executives Interviewed